How does Myasthenia Gravis affect the risk of developing urinary tract infections?

Current evidence does not directly link Myasthenia Gravis to an increased risk of urinary tract infections, but treatments for MG such as efgartigimod and inebilizumab may increase UTI risk as an adverse effect.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23782469
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How does Myasthenia Gravis affect the risk of developing urinary tract infections?

Tripdatabase
4 links
Zenodo (CERN European Organization for Nuclear Research)
Myasthenia Gravis and Thymoma
article

How does Myasthenia Gravis affect the risk of developing urinary tract infections?

Tripdatabase
article en

Abstract

Current evidence does not directly link Myasthenia Gravis to an increased risk of urinary tract infections, but treatments for MG such as efgartigimod and inebilizumab may increase UTI risk as an adverse effect.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 14%
Myasthenia Gravis and Thymoma
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
How does Myasthenia Gravis affect the risk of developing urinary tract infections? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS